These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 8212613

  • 1. [Experience with sulodexide (Vessel Due F) in diabetics with ischemic disease of the lower extremities].
    Utratová J, Mayer J, Elbl L, Vorlícek J, Prásek J.
    Vnitr Lek; 1993 Jun; 39(6):575-80. PubMed ID: 8212613
    [Abstract] [Full Text] [Related]

  • 2. [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical components in patients with diabetes type II and ischemia of the lower extremities].
    Turczyński B, Sroczyński J, Antoszewski Z, Matyszczyk B, Krupa G, Młynarski J, Strugala M.
    Pol Tyg Lek; 1993 Jun; 46(37-39):708-10. PubMed ID: 1669138
    [Abstract] [Full Text] [Related]

  • 3. Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial.
    Crepaldi G, Fellin R, Calabrò A, Baiocchi MR, Rossi A, Lenzi S, Descovich GC, Delmonte G, Gaddi A, Ventura A.
    Monogr Atheroscler; 1986 Jun; 14():215-21. PubMed ID: 3526129
    [No Abstract] [Full Text] [Related]

  • 4. [The significance of sulodexide in the prevention of obliterative atherosclerotic arterial disease of the lower limbs].
    Martino R, Benini D.
    Clin Ter; 1985 Mar 15; 112(5):429-37. PubMed ID: 4017468
    [No Abstract] [Full Text] [Related]

  • 5. [A trial of the use of the low-molecular heparin sulodexide in the therapy of diabetic nephropathy].
    Zalevskaia AG, Astamirova KhS, Karpova IA, Popova SG.
    Ter Arkh; 1998 Mar 15; 70(3):71-4. PubMed ID: 9575594
    [Abstract] [Full Text] [Related]

  • 6. [Sulodexide treatment approach in patients with atherosclerotic vascular disease with various localizations].
    Capone-Braga M, Tellini L, Boncompagni L, Bettoni M, Burali A, Bensi A.
    Clin Ter; 1987 Jan 15; 120(1):25-31. PubMed ID: 2973852
    [No Abstract] [Full Text] [Related]

  • 7. [The behavior of some metabolic and instrumental parameters in diabetics with arteriopathy of the lower extremities treated with increasing doses of glucuronyl-glycosaminoglycano-sulfate].
    Marigo S.
    Clin Ter; 1980 Jun 15; 93(5):503-18. PubMed ID: 7428314
    [No Abstract] [Full Text] [Related]

  • 8. Meta-analysis of some results of clinical trials on sulodexide therapy in peripheral occlusive arterial disease.
    Gaddi A, Galetti C, Illuminati B, Nascetti S.
    J Int Med Res; 1996 Jun 15; 24(5):389-406. PubMed ID: 8895043
    [Abstract] [Full Text] [Related]

  • 9. [The use of the descending genicular artery for long-term intra-arterial infusion in chronic ischemia of the extremities].
    Ivashchenko VV, Ezhelev VF.
    Vestn Khir Im I I Grek; 1992 Jun 15; 149(11-12):326-30. PubMed ID: 8594790
    [Abstract] [Full Text] [Related]

  • 10. [Drug therapy of high risk patients with diabetes mellitus].
    Krone W, Müller-Wieland D.
    Verh Dtsch Ges Inn Med; 1991 Jun 15; 97():238-42. PubMed ID: 1808892
    [No Abstract] [Full Text] [Related]

  • 11. [The effect of sulodexide, a glycosaminoglycan, on albuminuria in diabetic patients].
    Perusicová J, Skrha J.
    Vnitr Lek; 1997 Nov 15; 43(11):748-52. PubMed ID: 9650507
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Ozone therapy and viscosity of blood and plasma, distance of intermittent claudication and certain biochemical plasma components in patients with occlusive arteriosclerosis of the lower limbs].
    Turczyński B, Sroczyński J, Antoszewski Z, Matyszczyk B, Krupa G, Grzegorczyn S.
    Pol Tyg Lek; 1997 Nov 15; 46(37-39):700-3. PubMed ID: 1669136
    [Abstract] [Full Text] [Related]

  • 14. [Experience in the use of vessel due F (sulodexide) in patients with suppurative-necrotic forms of diabetic foot without critical ischemia].
    Svetukhin AM, Zemlianoĭ AB, Orudzheva SA, Titova MI, Rudneva VG, Elagina LV, Pavlova MV, Terekhova RP, Bozh'eva EI, Makhmudova LS.
    Ter Arkh; 2001 Nov 15; 73(4):31-3. PubMed ID: 11494443
    [Abstract] [Full Text] [Related]

  • 15. [Blood lipids and glucose tolerance in 100 patients with arteriosclerotic occlusions in the lower extremities].
    Beyrer K, May R, Sailer S.
    Wien Klin Wochenschr; 1968 May 17; 80(20):392-4. PubMed ID: 5728030
    [No Abstract] [Full Text] [Related]

  • 16. Hematologic changes in type 2 diabetic patients with various localizations of peripheral vascular disease.
    Tkác I, Tkácová R, Takác M, Lazúr J.
    Vasa; 1992 May 17; 21(4):360-4. PubMed ID: 1485469
    [Abstract] [Full Text] [Related]

  • 17. [Effect of sulodexide on hemorheological parameters in a group of patients with peripheral arteriosclerotic vascular disease].
    Calabrò A, Rossi A, Baiocchi MR, Coscetti G, Fellin R, Crepaldi G.
    Ric Clin Lab; 1985 May 17; 15 Suppl 1():455-63. PubMed ID: 4035227
    [Abstract] [Full Text] [Related]

  • 18. [Controlled study of the effect of sulodexide on peripheral diabetic macroangiopathy].
    Piva I, Lora L, Baso A, Erle G.
    G Clin Med; 1985 May 17; 66(1-2):37-45. PubMed ID: 3891485
    [No Abstract] [Full Text] [Related]

  • 19. [Transcutaneous oximetry in the diagnosis of ischemic disease of the lower extremities in diabetics].
    Urbanová R, Jirkovská A, Wosková V, Wohl P.
    Vnitr Lek; 2001 May 17; 47(5):330-2. PubMed ID: 11395879
    [Abstract] [Full Text] [Related]

  • 20. [Studies with Seniosan in arteriosclerosis of the abdominal aorta and-or lower extremities].
    Blomquist HE.
    Ann Chir Gynaecol Fenn; 1968 May 17; 57(2):218-20. PubMed ID: 4237173
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.